Aptorum Research Development from 2010 to 2026

APM Stock  USD 0.81  0.07  9.46%   
Aptorum Group Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to drop to about 2.1 M. During the period from 2010 to 2026, Aptorum Group Research Development quarterly data regression pattern had sample variance of 10.5 T and median of  2,560,323. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
2.2 M
Current Value
2.1 M
Quarterly Volatility
3.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Aptorum Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptorum Group's main balance sheet or income statement drivers, such as Interest Expense of 125.6 K, Selling General Administrative of 1.6 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 28.05, Dividend Yield of 0.0079 or PTB Ratio of 0.79. Aptorum financial statements analysis is a perfect complement when working with Aptorum Group Valuation or Volatility modules.
  
Build AI portfolio with Aptorum Stock
Check out the analysis of Aptorum Group Correlation against competitors.
Evaluating Aptorum Group's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptorum Group Ltd's fundamental strength.

Latest Aptorum Group's Research Development Growth Pattern

Below is the plot of the Research Development of Aptorum Group Ltd over the last few years. It is Aptorum Group's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptorum Group's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Aptorum Research Development Regression Statistics

Arithmetic Mean4,331,864
Geometric Mean3,540,909
Coefficient Of Variation74.94
Mean Deviation2,606,433
Median2,560,323
Standard Deviation3,246,466
Sample Variance10.5T
Range9.6M
R-Value0.30
Mean Square Error10.3T
R-Squared0.09
Significance0.25
Slope190,648
Total Sum of Squares168.6T

Aptorum Research Development History

20262.1 M
20252.2 M
20241.9 M
20235.2 M
20229.2 M
202110.9 M
202011.6 M

About Aptorum Group Financial Statements

Aptorum Group investors utilize fundamental indicators, such as Research Development, to predict how Aptorum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development2.2 M2.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Aptorum Group is a strong investment it is important to analyze Aptorum Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aptorum Group's future performance. For an informed investment choice regarding Aptorum Stock, refer to the following important reports:
Check out the analysis of Aptorum Group Correlation against competitors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Biotechnology sector continue expanding? Could Aptorum diversify its offerings? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aptorum Group data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.31)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.06)
Return On Equity
(0.14)
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Aptorum Group's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aptorum Group represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Aptorum Group's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.